GLA
Fabry Disease: GLA Sequencing
Key Information
Lab:
TAT:
21 days
Price:
$1,000
CPT Code(s):
81405
Test Code:
DGLA
Prenatal Samples Accepted
Fabry Disease: GLA Sequencing
GLA sequencing is a molecular test used to identify variants in the gene associated with Fabry disease. This test can also confirm a diagnosis and identify disease-causing variants within a family to facilitate carrier screening.
Fabry disease
Clinical Information
Fabry disease is a lysosomal storage disorder in which absent or reduced production of enzyme alpha-galactosidase A leads to the systemic accumulation of globotriaoslyceramide.
Total absence of enzyme production results in the more severe, classic form of Fabry disease, while reduced production of alpha-galactosidase A typically often involves milder symptoms that appear later in life. Episodic pain, angiokeratosis, and hypohydrosis are frequently seen in patients with Fabry disease as well as corneal clouding and hearing loss. Gastrointestinal issues and breathing problems are common, and complications including cardiac abnormalities, kidney disease, and strokes can be life-threatening.
Although Fabry disease is an X-linked disorder that primarily affects males, carrier females may become symptomatic. This condition occurs in approximately 1 in 55,000 males, and the development of enzyme replacement therapy has greatly improved the prognosis for many patients.
Technical Information
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis may be available for familial pathogenic or likely pathogenic variants; full sequencing of the GLA gene is not available. For variants identified at external laboratories, GGC will need to review the variant classification prior to sample receipt.
Prenatal diagnosis is not available for variants of uncertain clinical significance. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen to confirm that targeted testing can be accepted.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Associated Tests
- Comprehensive Cardiac NGS Panel
- Comprehensive Pulmonary NGS Panel
- Dilated & Arrhythmogenic Cardiomyopathy NGS Panel
- Fabry Disease: Alpha-galactosidase Enzyme Analysis
- Lysosomal Storage Disease Enzyme Panel
- Lysosomal Storage Disease Enzyme Panel (DBS)
- Maternal Cell Contamination
- Neurological Enzyme Panel
- Non-Immune Hydrops NGS Panel
- Targeted Analysis: Known Familial Variant
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
